[Federal Register Volume 67, Number 225 (Thursday, November 21, 2002)]
[Notices]
[Page 70219]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-29614]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant a Partially Exclusive Patent License; 
RMZ Biotech, Inc.

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to RMZ Biotech, Inc., a revocable, nonassignable, partially 
exclusive, license to practice worldwide the Government-Owned invention 
described in U.S. Patent Number 5,895,651 entitled ``Recombinant Dengue 
Virus Envelop Protein/Maltose-Binding Protein Antigens and Subunit 
Vaccine Compositions Containing Said Antigens,'' issued 20 April 1999, 
in the field of rapid diagnostic test kits for Dengue Virus infection.

DATES: Anyone wishing to object to the grant of this license has 
fifteen (15) days from the date of this notice to file written 
objections along with supporting evidence, if any. Written objections 
are to be filed with the Office of Technology Transfer, Naval Medical 
Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500, 
telephone (301) 319-7428.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone (301) 319-7428.

    Dated: November 12, 2002.
R.E. Vincent II,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. 02-29614 Filed 11-20-02; 8:45 am]
BILLING CODE 3810-FF-M